Butt JH, Nicolau JC, Verma S, Docherty KF, et al. Efficacy and Safety of Dapagliflozin According to Aetiology in Heart Failure with Reduced Ejection Fraction: Insights from the DAPA-HF trial. Eur J Heart Fail 2021 Feb 16. doi: 10.1002/ejhf.2124.
PMID: 33594755